SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Herman James L (Last) (First) (Middle) 2525 WEST END AVENUE, SUITE 950 (Street) NASHVILLE TN 37203 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/14/2013	3. Issuer Name and Ticker or Trading Symbol CUMBERLAND PHARMACEUTICALS INC [ CPIX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) See Remarks	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,259	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(1)	10/09/2013	Common Stock	74,000	6	D

Explanation of Responses:

1. The option became exercisable as to 18,500 shares on each of December 31, 2003, 2004, 2005 and 2006.

Remarks:

V.P. National Accounts and Corporate Compliance Officer Exhibit List Exhibit 24.3 - Power of Attorney

	/s/ James L. Herman	03/20/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

                                                                    EXHIBIT 24.3

                                POWER OF ATTORNEY

Know  all by  these  presents,  I  hereby  appoint  Rick S.  Greene  and Jean W.
Marstiller,  or any one of them, to act as my agent and attorney-in-fact for the
purpose of completing, executing and filing on my behalf with the Securities and
Exchange  Commission,  the  NASDAQ  Stock  Market LLC or any other  exchange  or
self-regulatory  body, any Form 3 "Initial Statement of Beneficial  Ownership of
Securities",   Form  4  "Statement  of  Changes  in   Beneficial   Ownership  of
Securities",  Form 5 "Annual  Statement of Beneficial  Ownership of Securities",
Form 144 "Notice of Proposed Sale of Securities",  Schedule 13D pursuant to Rule
13d-101 of the  Securities  Exchange Act of 1934,  or any other  similar form to
report  securities  ownership  that  may,  in the  opinion  of any  of  them  be
necessary,   with  respect  to  any  transaction  in  securities  of  Cumberland
Pharmaceuticals Inc.

Nothing  herein shall relieve me of the  responsibility  for the accuracy of the
information  and  representations  contained in any Form 3, Form 4, Form 5, Form
144, Schedule 13D, or other similar form completed,  executed and filed pursuant
to this power of attorney.

This power of attorney shall  supersede all similar prior powers of attorney and
will remain effective as to the agents and  attorneys-in-fact  referred to above
until I revoke  or amend it by  written  notice  to such  persons  or until  the
undersigned  is no  longer  required  to file  Form 3, Form 4, Form 5, Form 144,
Schedule 13D or other  similar form  completed,  executed and filed  pursuant to
this power of attorney.

IN WITNESS  WHEREOF,  the  undersigned  has caused  this Power of Attorney to be
executed on this 19th day of March 2013.
                                        /s/ James L. Herman
                                        ---------------------------------------
                                        James L. Herman